Cogent Biosciences, Inc. (COGT) Total liabilities 2018–2021
Cogent Biosciences, Inc. (COGT) total liabilities at each fiscal year-end, per SEC filings.
$16.2MFY2021 · since FY2018: $20.8M → $16.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | $16.2M | -8.0% |
| FY2020 | $17.7M | -31.3% |
| FY2019 | $25.7M | +23.5% |
| FY2018 | $20.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More COGT financial trends
COGT RevenueCOGT Net incomeCOGT Net marginCOGT Gross profitCOGT Gross marginCOGT Operating incomeCOGT Operating marginCOGT Operating cash flowCOGT Free cash flowCOGT Capital expendituresCOGT Return on equityCOGT Stock buybacksCOGT Dividends paidCOGT Total assetsCOGT Shareholders’ equityCOGT overview →